TCL Archive With a “B” from USPSTF, Low-Dose CT Screening For Lung Cancer Earns Coverage Under ACA August 2, 2013
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive In Brief: No More Shifts Planned For Treatment Programs; Groups Seek Surgeon, Radiologist Incentives August 29, 1975
